Metraipolis › archive › dc_3c178ce02ff3

STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer — Europe PMC PMID:41331871

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41331871
DOI
10.1186/s13046-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T00:56:13.406Z
SHA-256 of the archived text
12de431f452d13ed5e023a13c47b3fc474eab17e2fe9fee453824abc1725efbe
Stable URL of this page
https://metraipolis.com/documento/dc_3c178ce02ff3

How to cite

STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer — Europe PMC PMID:41331871 — Europe PMC (en), https://europepmc.org/article/MED/41331871 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3c178ce02ff3 (Metraipolis archive dc_3c178ce02ff3, sha256 12de431f452d13ed5e023a13c47b3fc474eab17e2fe9fee453824abc1725efbe)
BibTeX
@misc{dc3c178ce02ff3,
  title = {STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer — Europe PMC PMID:41331871},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41331871},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3c178ce02ff3; sha256 12de431f452d13ed5e023a13c47b3fc474eab17e2fe9fee453824abc1725efbe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41331871. Agents can read the archived copy with the MCP tool read_document.